<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38520594</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>A pilot study to assess blood-brain barrier permeability in long COVID.</ArticleTitle><Pagination><StartPage>830</StartPage><EndPage>834</EndPage><MedlinePgn>830-834</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-024-00877-8</ELocationID><Abstract><AbstractText>The etiology of brain fog associated with long COVID is not clear. Based on some preliminary work, disruption of the blood-brain barrier has been hypothesized, but has not been tested in patients with long COVID. In this case-control pilot study, we evaluated blood-brain barrier permeability in patients with long COVID and subjective memory loss or brain fog. We used 99&#xa0;m Technetium diethylenetriaminepentaacetic acid single-photon emission computed tomography (SPECT) to measure blood-brain barrier permeability and a telephone assessment (T-cog) to measure cognitive function. The blood-brain barrier permeability was quantified via SPECT standard uptake value (SUV). We assessed the blood-brain barrier permeability in 14 long COVID patients and 10 control participants without subjective cognitive impairment or brain fog. Participants in the two groups were similar in age. The long COVID group had more comorbidities compared to the control group. There was no difference in the SUVs in the long COVID (0.22&#x2009;&#xb1;&#x2009;0.12) vs the control (0.17&#x2009;&#xb1;&#x2009;0.04) group. There was no difference in the T-cog results in the two groups either. We found no evidence of a difference in blood-brain permeability in patients with long COVID when compared to controls without a known history of COVID-19 infection. Larger studies are needed to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. agupta@kumc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. agupta@kumc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comfort</LastName><ForeName>Branden</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biostatistics &amp; Data Science, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics &amp; Data Science, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG055666</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015899" MajorTopicYN="Y">Tomography, Emission-Computed, Single-Photon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010539" MajorTopicYN="N">Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood-brain barrier</Keyword><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Memory loss</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>23</Day><Hour>20</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>23</Day><Hour>12</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38520594</ArticleId><ArticleId IdType="doi">10.1007/s11682-024-00877-8</ArticleId><ArticleId IdType="pii">10.1007/s11682-024-00877-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bonetto, V., Pasetto, L., Lisi, I., Carbonara, M., Zangari, R., Ferrari, E., Punzi, V., Luotti, S., Bottino, N., Biagianti, B., Moglia, C., Fuda, G., Gualtierotti, R., Blasi, F., Canetta, C., Montano, N., Tettamanti, M., Camera, G., Grimoldi, M., ... Zanier, E. R. (2022). Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Frontiers in Immunology, 13, 1070379. https://doi.org/10.3389/fimmu.2022.1070379</Citation></Reference><Reference><Citation>Chagnot, A., Barnes, S. R., &amp; Montagne, A. (2021). Magnetic resonance imaging of blood-brain barrier permeability in dementia. Neuroscience, 474, 14&#x2013;29. https://doi.org/10.1016/j.neuroscience.2021.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.08.003</ArticleId><ArticleId IdType="pubmed">34400249</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli, F., Carregari, V. C., Veras, F. P., Silva, L. S., Nogueira, M. H., Antunes, A., Vendramini, P. H., Valen&#xe7;a, A. G. F., Brand&#xe3;o-Teles, C., Zuccoli, G. D. S., Reis-de-Oliveira, G., Silva-Costa, L. C., Saia-Cereda, V. M., Smith, B. J., Codo, A. C., de Souza, G. F., Muraro, S. P., Parise, P. L., Toledo-Teixeira, D. A., ... Martins-de-Souza, D. (2022). Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America, 119(35), e2200960119. https://doi.org/10.1073/pnas.2200960119</Citation></Reference><Reference><Citation>Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., Lange, F., Andersson, J. L. R., Griffanti, L., Duff, E., Jbabdi, S., Taschler, B., Keating, P., Winkler, A. M., Collins, R., Matthews, P. M., Allen, N., Miller, K. L., Nichols, T. E., &amp; Smith, S. M. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 604(7907), 697&#x2013;707. https://doi.org/10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilad, R., Lampl, Y., Eilam, A., Boaz, M., &amp; Loyberboim, M. (2012). SPECT-DTPA as a tool for evaluating the blood-brain barrier in post-stroke seizures. Journal of Neurology, 259(10), 2041&#x2013;2044. https://doi.org/10.1007/s00415-012-6445-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6445-2</ArticleId><ArticleId IdType="pubmed">22323212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, A., Bansal, A., Young, K., Gautam, A., Donald, J., Comfort, B., &amp; Montgomery, R. (2023). Blood&#x2013;Brain Barrier Permeability in ESKD&#x2014;A Proof-of-Concept Study. Journal of the American Society of Nephrology. https://doi.org/10.1681/ASN.0000000000000167</Citation></Reference><Reference><Citation>Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., &amp; Furui, S. (2015). Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology, 276(1), 228&#x2013;232. https://doi.org/10.1148/radiol.2015142690</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2015142690</ArticleId><ArticleId IdType="pubmed">25942417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj, D., Aenlle, K. K., Cohen, J., Mathew, A., Isler, D., Pangeni, R. P., Nathanson, L., Theoharides, T. C., &amp; Klimas, N. G. (2023). COVID-19 and long COVID: Disruption of the neurovascular unit, blood-brain barrier, and tight junctions. Neuroscientist, 10738584231194927. https://doi.org/10.1177/10738584231194927</Citation></Reference><Reference><Citation>Krasemann, S., Haferkamp, U., Pfefferle, S., Woo, M. S., Heinrich, F., Schweizer, M., Appelt-Menzel, A., Cubukova, A., Barenberg, J., Leu, J., Hartmann, K., Thies, E., Littau, J. L., Sepulveda-Falla, D., Zhang, L., Ton, K., Liang, Y., Matschke, J., Ricklefs, F., ... Pless, O. (2022). The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports, 17(2), 307&#x2013;320. https://doi.org/10.1016/j.stemcr.2021.12.011</Citation></Reference><Reference><Citation>Lee, M. H., Perl, D. P., Steiner, J., Pasternack, N., Li, W., Maric, D., Safavi, F., Horkayne-Szakaly, I., Jones, R., Stram, M. N., Moncur, J. T., Hefti, M., Folkerth, R. D., &amp; Nath, A. (2022). Neurovascular injury with complement activation and inflammation in COVID-19. Brain, 145(7), 2555&#x2013;2568. https://doi.org/10.1093/brain/awac151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y.-H., Chen, Y., Wang, Q.-H., Wang, L.-R., Jiang, L., Yang, Y., Chen, X., Li, Y., Cen, Y., Xu, C., Zhu, J., Li, W., Wang, Y.-R., Zhang, L.-L., Liu, J., Xu, Z.-Q., &amp; Wang, Y.-J. (2022). One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurology, 79(5), 509&#x2013;517. https://doi.org/10.1001/jamaneurol.2022.0461</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId><ArticleId IdType="pmc">8905512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorberboym, M., Lampl, Y., &amp; Sadeh, M. (2003). Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke. Journal of Nuclear Medicine, 44(12), 1898&#x2013;1904.</Citation><ArticleIdList><ArticleId IdType="pubmed">14660714</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke, J., L&#xfc;tgehetmann, M., Hagel, C., Sperhake, J. P., Schr&#xf6;der, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., Dottermusch, M., Heinemann, A., Pfefferle, S., Schwabenland, M., Sumner Magruder, D., Bonn, S., Prinz, M., Gerloff, C., P&#xfc;schel, K., ... Glatzel, M. (2020). Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. The Lancet Neurology, 19(11), 919&#x2013;929. https://doi.org/10.1016/S1474-4422(20)30308-2</Citation></Reference><Reference><Citation>Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D'Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Chui, H. C., Law, M., Toga, A. W., &amp; Zlokovic, B. V. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine, 25(2), 270&#x2013;276. https://doi.org/10.1038/s41591-018-0297-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0297-y</ArticleId><ArticleId IdType="pubmed">30643288</ArticleId><ArticleId IdType="pmc">6367058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen, L. T., Mukerji, S. S., &amp; Mejia, N. I. (2022). Post-acute neurological consequences of COVID-19: An unequal burden. Nature Medicine, 28(1), 20&#x2013;23. https://doi.org/10.1038/s41591-021-01647-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr, J. M., Wardlaw, J., Ferguson, K., MacLullich, A., Deary, I. J., &amp; Marshall, I. (2003). Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. Journal of Neurology, Neurosurgery, and Psychiatry, 74(1), 70&#x2013;76. https://doi.org/10.1136/jnnp.74.1.70</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.1.70</ArticleId><ArticleId IdType="pubmed">12486269</ArticleId><ArticleId IdType="pmc">1738177</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein, S. R., Ramelli, S. C., Grazioli, A., Chung, J.-Y., Singh, M., Yinda, C. K., Winkler, C. W., Sun, J., Dickey, J. M., Ylaya, K., Ko, S. H., Platt, A. P., Burbelo, P. D., Quezado, M., Pittaluga, S., Purcell, M., Munster, V. J., Belinky, F., Ramos-Benitez, M. J., ... Consortium, N. C.-A. (2022). SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature, 612(7941), 758&#x2013;763. https://doi.org/10.1038/s41586-022-05542-y</Citation></Reference><Reference><Citation>Venkataramani, V., &amp; Winkler, F. (2022). Cognitive deficits in long Covid-19. The New England Journal of Medicine, 387(19), 1813&#x2013;1815. https://doi.org/10.1056/NEJMcibr2210069</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingaropoli, M. A., Iannetta, M., Piermatteo, L., Pasculli, P., Latronico, T., Mazzuti, L., Campogiani, L., Duca, L., Ferraguti, G., De Michele, M., Galardo, G., Pugliese, F., Antonelli, G., Andreoni, M., Sarmati, L., Lichtner, M., Turriziani, O., Ceccherini-Silberstein, F., Liuzzi, G. M., ... Ciardi, M. R. (2022). Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients. Cells, 11(16). https://doi.org/10.3390/cells11162480</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>